Transferrin modified PEG-PLA-resveratrol conjugates: In vitro and in vivo studies for glioma

European Journal of Pharmacology

Volumn 718, Issue 1-3, 2013, Pages 41-47

  Guo, Wanhua ^a   Li, Aimei ^a   Jia, Zhijun ^a   Yuan, Yi ^b   Dai, Haifeng ^c   Li, Hongxiu ^b  

^a NANJING UNIVERSITY   (China)

^b Ningbo Mingzhou Hospital   (China)

^c JIANGSU CANCER HOSPITAL   (China)

Author keywords

Glioma; In vitro and in vivo; PEG PLA; Resveratrol; Transferrin

Indexed keywords

MACROGOL; NANOPARTICLE; POLYCAPROLACTONE; RESVERATROL; TRANSFERRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER SIZE; CELL VIABILITY; CONTROLLED STUDY; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG DISTRIBUTION; DRUG DOSAGE FORM COMPARISON; DRUG UPTAKE; GLIOMA; GLIOMA CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT;

GLIOMA; IN VITRO AND IN VIVO; PEG-PLA; RESVERATROL; TRANSFERRIN;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BIOLOGICAL TRANSPORT; BRAIN; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG CARRIERS; GLIOMA; LACTIC ACID; MALE; MOLECULAR TARGETED THERAPY; NANOPARTICLES; POLYETHYLENE GLYCOLS; POLYMERS; RATS; STILBENES; SURVIVAL ANALYSIS; TRANSFERRIN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84887037721     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.09.034     Document Type: Article

References (32)

1. D. Albani, L. Polito, and G Forloni Sirtuins as novel targets for Alzheimer's disease and other neurodegenerative disorders: experimental and genetic evidence Journal of Alzheimer's Disease 19 2010 11 26
2. A. Behin, K. Hoang-Xuan, AF. Carpentier, and J.Y. Delattre Primary brain tumours in adults Lancet 361 2003 323 331 (Pubitemid 36126198)
3. A. Borriello, V. Cucciolla, F. Della Raqione, and P. Galletti Dietary polyphenols: focus on resveratrol, a promising agent in the prevention of cardiovascular diseases and control of glucose homeostasis Nutrition, Metabolism and Cardiovascular Diseases 20 2010 618 625
4. A. Calzolari, L.M. Larocca, S. Deaglio, V. Finisguerra, A. Boe, C. Raggi, L. Ricci-Vitani, F. Pierconti, F. Malavasi, R. De Maria, U. Testa, and R. Pallini Transferrin receptor 2 is frequently and highly expressed in glioblastomas Translational Oncology 3 2010 123 134
5. R. Castino, A. Pucer, R. Veneroni, F. Morani, C. Peracchio, T.T. Lah, and C. Isidoro Resveratrol reduces the invasive growth and promotes the acquisition of a long-lasting differentiated phenotype in human glioblastoma cells Journal of Agricultural and Food Chemistry 59 2011 4264 4272
6. J. Chang, A. Paillard, C. Passirani, M. Morille, J.P. Benoit, D. Betbeder, and E. Garcion Transferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cells Pharmaceutical Research 29 2012 1495 1505
7. T.R. Daniels, T. Delgado, G. Helguera, and M.L. Penichet The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells Clinical Immunology 121 2006 159 176 (Pubitemid 44572972)
8. N. Gagliano, G. Aldini, G. Colombo, R. Rossi, R. Colombo, M. Gioia, A. Milzani, and I. Dalle-Donne The potential of resveratrol against human gliomas Anticancer Drugs 21 2010 140 150
9. X. Gao, W. Tao, W. Lu, Q. Zhang, Y. Zhang, X. Jiang, and S. Fu Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration Biomaterials 27 2006 3482 3490
10. R. Gref, Y. Minamitake, M.T. Peracchia, V. Trubetskoy, V. Torchilin, and R. Langer Biodegradable long-circulating polymeric nanospheres Science 263 1994 1600 1603 (Pubitemid 24128361)
11. K.B. Harikumar, and B.B. Aggarwal Resveratrol: a multitargeted agent for age-associated chronic diseases Cell Cycle 7 2008 1020 1035
12. R.Q. Huang, Y.H. Qu, W.L. Ke, J.H. Zhu, Y.Y. Pei, and C. Jiang Efficient gene delivery targeted to the brain using a transferrin-conjugated polyethyleneglycol-modified polyamidoamine dendrimer FASEB Journal 21 2007 1117 1125 (Pubitemid 46495701)
13. H. Jiang, X. Shang, H. Wu, G. Huang, Y. Wang, S. Al-Holou, S.C. Gautam, and M. Chopp Combination treatment with resveratrol and sulforaphane induces apoptosis in human U251 glioma cells Neurochemical Research 35 2010 152 161
14. M.K. Khan, G.K. Hunter, M. Vogelbaum, J.H. Suh, and S.T. Chao Evidence-based adjuvant therapy for gliomas: current concepts and newer developments Indian Journal of Cancer 46 2009 96 107
15. W. Lu, Y. Zhang, Y.Z. Tan, K.L. Hu, X.G. Jiang, and S.K. Fu Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery Journal of Controlled Release 107 2005 428 448 (Pubitemid 41393353)
16. T. Ma, Z.G. Zhu, Y.B Ji, Y. Zhang, Y.Y. Yu, B.Y. Liu, H.R. Yin, and Y.Z. Lin Correlation of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase with sensitivity of gastrointestinal cancer cells to 5-fluorouracil and 5-fluoro-2¢-deoxyuridine World Journal of Gastroenterology 10 2004 172 176 (Pubitemid 38195255)
17. M.S. Muthu, and S. Singh Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders Nanomedicine 4 2009 105 118
18. J.C. Olivier, R. Huertas, H.J. Lee, F. Calon, and W.M. Pardridge Synthesis of pegylated immunonanoparticles Pharmaceutical Research 19 2002 1137 1143 (Pubitemid 34984997)
19. H. Pan, L. Han, W. Chen, M. Yao, and W. Lu Targeting to tumor necrotic regions with biotinylated antibody and streptavidin modified liposomes Journal of Controlled Release 125 2008 228 235
20. Z. Pang, H. Gao, Y. Yu, L. Guo, J. Chen, S. Pan, J. Ren, Z. Wen, and X. Jiang Enhanced intracellular delivery and chemotherapy for glioma rats by transferrin-conjugated biodegradable polymersomes loaded with RSVorubicin Bioconjugate Chemistry 22 2011 1171 1180
21. J. Panyam, and V. Labhasetwar Biodegradable nanoparticles for drug and gene delivery to cells and tissue Advanced Drug Delivery Reviews 55 2003 329 347 (Pubitemid 36297053)
22. V. Sanna, A.M. Roggio, S. Siliani, M. Piccinini, S. Marceddu, A. Mariani, and M. Sechi Development of novel cationic chitosan- and anionic alginate-coated poly(d,l-lactide-co-glycolide) nanoparticles for controlled release and light protection of resveratrol International Journal of Nanomedicine 7 2012 5501 5516
23. S. Sathornsumetee, and J.N. Rich New approaches to primary brain tumor treatment Anticancer Drugs 17 2006 1003 1016 (Pubitemid 44454776)
24. I.A. Siddiqui, V.M. Adhami, D.J. Bharali, B.B. Hafeez, M. Asim, S.I. Khwaja, N. Ahmad, H. Cui, S.A. Mousa, and H. Mukhtar Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate Cancer Research 69 2009 1712 1716
25. W. Tian, X. Ying, J. Du, J. Guo, Y. Men, Y. Zhang, R.J. Li, H.J. Yao, J.N. Lou, L.R. Zhang, and W.L. Lu Enhanced efficacy of functionalized epirubicin liposomes in treating brain glioma-bearing rats European Journal of Pharmaceutical Sciences 41 2010 232 243
26. Y. Tsutsui, K. Tomizawa, M. Nagita, H. Michiue, T. Nishiki, I. Ohmori, M. Seno, and H. Matsui Development of bionanocapsules targeting brain tumors Journal of Controlled Release 122 2007 159 164 (Pubitemid 47361404)
27. Wang, YY., Liu, S.C., Yang, Z., Zhang, T., 2011. Impaired hippocampal synaptic plasticity in C6 glioma-bearing rats. J Neurooncol 103: 469-477.
28. J. Yang, D.T. Nagasawa, M. Spasic, M. Amolis, W. Choy, H.M. Garcia, R.M. Prins, L.M. Liau, and I. Yang Endogenous vaults and bioengineered vault nanoparticles for treatment of glioblastomas: implications for future targeted therapies Neurosurgery Clinics of North America 23 2012 451 458
29. X. Ying, H. Wen, W.L. Lu, J. Du, J. Guo, W. Tian, Y. Men, Y. Zhang, R.J. Li, T.Y. Yang, D.W. Shang, J.N. Lou, L.R. Zhang, and Q. Zhang Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals Journal of Controlled Release 141 2010 183 192
30. L. Zhang, S. Zhu, L. Qian, Y. Pei, Y. Qiu, and Y. Jiang RGD-modified PEG-PAMAM-DOX conjugates: in vitro and in vivo studies for glioma European Journal of Pharmaceutics and Biopharmaceutics 79 2011 232 240
31. P. Zhang, L. Hu, Q. Yin, L. Feng, and Y. Li Transferrin-modified c[RGDfK]-paclitaxel loaded hybrid micelle for sequential blood-brain barrier penetration and glioma targeting therapy Molecular Pharmaceutics 9 2012 1590 1598
32. S. Zhu, M. Hong, G. Tang, L. Qian, J. Lin, Y. Jiang, and Y. Pei Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: the effects of PEGylation degree and drug conjugation style Biomaterials 31 2010 1360 1371